scholarly journals Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria

2007 ◽  
Vol 59 (6) ◽  
pp. 1208-1209 ◽  
Author(s):  
B. Rouveix
Keyword(s):  
Drug Resistance ◽  
Pathogenic Bacteria ◽  
Multiple Drug Resistance ◽  
Efflux Pumps ◽  
Multiple Drug ◽  
Clinical Implications

scholarly journals Mechanisms of bacterial multiresistance to antibiotics

2018 ◽  
Vol 16 (3) ◽  
pp. 4-17 ◽  
Author(s):  
Olga M. Zemlyanko ◽  
Tatyana M. Rogoza ◽  
Galina A. Zhouravleva
Keyword(s):  
Drug Resistance ◽  
Clinical Practice ◽  
Resistance Genes ◽  
Horizontal Transfer ◽  
Pathogenic Bacteria ◽  
Multiple Drug Resistance ◽  
Multiple Drug ◽  
Bacterial Strains ◽  
Current Review

Multiple drug resistance (MDR) to widening range of antibiotics emerging in increasing variety of pathogenic bacteria is a serious threat to the health of mankind nowadays. This is partially due to an uncontrolled usage of antibiotics not only in clinical practice, but also in various branches of agriculture. MDR is affected by two mechanisms: (1) accumulation of resistance genes as a result of intensive selection caused by antibiotics, and (2) active horizontal transfer of resistance genes. To unveil the reasons of bacterial multiresistance to antibiotics, it is necessary to understand the mechanisms of antibiotics action as well as the ways how either resistance to certain antibiotics emerge or resistance genes accumulate and transfer among bacterial strains. Current review is devoted to all these problems.

scholarly journals Multidrug Therapy and Evolution of Antibiotic Resistance: When Order Matters

2012 ◽  
Vol 78 (17) ◽  
pp. 6137-6142 ◽  
Author(s):  
Gabriel G. Perron ◽  
Sergey Kryazhimskiy ◽  
Daniel P. Rice ◽  
Angus Buckling
Keyword(s):  
Drug Resistance ◽  
Multidrug Resistance ◽  
Pathogenic Bacteria ◽  
Health Workers ◽  
Multiple Drug Resistance ◽  
Sequential Therapy ◽  
Resistant Bacteria ◽  
Multiple Drug ◽  
Multidrug Therapy

ABSTRACTThe evolution of drug resistance among pathogenic bacteria has led public health workers to rely increasingly on multidrug therapy to treat infections. Here, we compare the efficacy of combination therapy (i.e., using two antibiotics simultaneously) and sequential therapy (i.e., switching two antibiotics) in minimizing the evolution of multidrug resistance. Usingin vitroexperiments, we show that the sequential use of two antibiotics againstPseudomonas aeruginosacan slow down the evolution of multiple-drug resistance when the two antibiotics are used in a specific order. A simple population dynamics model reveals that using an antibiotic associated with high costs of resistance first minimizes the chance of multidrug resistance evolution during sequential therapy under limited mutation supply rate. As well as presenting a novel approach to multidrug therapy, this work shows that costs of resistance not only influences the persistence of antibiotic-resistant bacteria but also plays an important role in the emergence of resistance.

Role of nanomaterials in deactivating multiple drug resistance efflux pumps – A review

2022 ◽  
Vol 204 ◽  
pp. 111968
Author(s):  
Nibedita Dey ◽  
C. Kamatchi ◽  
A.S. Vickram ◽  
K. Anbarasu ◽  
S. Thanigaivel ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Multiple Drug Resistance ◽  
Efflux Pumps ◽  
Multiple Drug

Do Multiple Drug Resistance Transporters Interfere with Cell Functioning under Normal Conditions?

2020 ◽  
Vol 85 (12-13) ◽  
pp. 1560-1569
Author(s):  
D. A. Knorre ◽  
K. V. Galkina ◽  
T. Shirokovskikh ◽  
A. Banerjee ◽  
R. Prasad
Keyword(s):  
Drug Resistance ◽  
Multiple Drug Resistance ◽  
Multiple Drug

scholarly journals Amelioration of the Cost of Conjugative Plasmid Carriage in Eschericha coli K12

Genetics ◽  
2003 ◽  
Vol 165 (4) ◽  
pp. 1641-1649
Author(s):  
Cecilia Dahlberg ◽  
Lin Chao
Keyword(s):  
Drug Resistance ◽  
Multiple Drug Resistance ◽  
Conjugative Plasmid ◽  
Energetic Cost ◽  
Multiple Drug ◽  
Genetic Changes ◽  
Batch Cultures ◽  
Transfer Rates ◽  
Bacterial Plasmid ◽  
The Cost

Abstract Although plasmids can provide beneficial functions to their host bacteria, they might confer a physiological or energetic cost. This study examines how natural selection may reduce the cost of carrying conjugative plasmids with drug-resistance markers in the absence of antibiotic selection. We studied two plasmids, R1 and RP4, both of which carry multiple drug resistance genes and were shown to impose an initial fitness cost on Escherichia coli. To determine if and how the cost could be reduced, we subjected plasmid-containing bacteria to 1100 generations of evolution in batch cultures. Analysis of the evolved populations revealed that plasmid loss never occurred, but that the cost was reduced through genetic changes in both the plasmids and the bacteria. Changes in the plasmids were inferred by the demonstration that evolved plasmids no longer imposed a cost on their hosts when transferred to a plasmid-free clone of the ancestral E. coli. Changes in the bacteria were shown by the lowered cost when the ancestral plasmids were introduced into evolved bacteria that had been cured of their (evolved) plasmids. Additionally, changes in the bacteria were inferred because conjugative transfer rates of evolved R1 plasmids were lower in the evolved host than in the ancestral host. Our results suggest that once a conjugative bacterial plasmid has invaded a bacterial population it will remain even if the original selection is discontinued.

Sign in / Sign up

Export Citation Format

Share Document